Spatial Transcriptomics of ER+ Her2- Breast cancer
Source: CNGBdb Project (ID CNP0005631)
Source: CNGBdb Project (ID CNP0005631)
0 0
Description: Stereo-seq experiments were performed on 4 samples of primary ER+HER2- breast cancer. These four early breast cancer patients received 5-10 years endocrine therapy after surgery and chemotherapy. Two patients were endocrine resistant and the other two were endocrine sensitive.
Data type: Genome sequencing; Transcriptome or Gene expression
Sample scope: Multiisolate
Submitter: 李则雨(LIZeyu); 深圳华大生命科学研究院
Literatures
- PMID: 39023171
Release date: 2026-04-24
Last updated: 2026-04-24
DOI: 10.26036/CNP0005631
Data size: 2.14TB